🔬 Bioscience Association Manitoba Applauds Government Action to Advance Bioscience Research and Clinical Trials in Manitoba

🤖 ImmunoPrecise Validates LENSai Epitope Mapping Platform Across Broad Range of Unseen Therapeutic Targets Beyond Training Data

👩‍⚕️ Synedgen Promotes Dr. Laura Saward to Chief Executive Officer and Appoints Dr. Kenton Gregory to Chief Medical Officer

🧬 Anne Wojcicki’s nonprofit gets court approval to buy 23andMe for $305 million

💡 Portal Biotech Raises $35 Million Series A, Leveraging AI to Deliver the World’s First Full-Length Single-Molecule Protein Sequencer

🏥 Shriners Children’s to open $153M medical research facility in Atlanta

🚨 Biotech & Pharma Industry Highlights – Latest Announcements 🚨 Here are some recent developments shaping innovation across neuroscience, oncology, mental health, and regenerative medicine:

🔬 New Data for Nusinersen Underscore Biogen’s Commitment to Advancing Clinical Research to Improve Outcomes in SMA Biogen presents new clinical data showing improved motor outcomes with a higher dose of nusinersen in SMA patients.

💊 PSYENCE GROUP INC. Announces Update on Previously Announced Non-Brokered Private Placement of Common Shares C$600,000 raised to support further development of psilocybin-based mental health therapies.

🧬 FDA Grants RMAT Designation for enGene’s Detalimogene A significant milestone for enGene’s bladder cancer gene therapy candidate, enabling faster review and development.

🧠 Biogen to Advance Investigational SMA Asset to Registrational Studies Positive Phase 1 results prompt progression of once-yearly ASO therapy for SMA to late-stage trials.

🧪 Enveric Biosciences Announces Data on EB-003 Lead compound targets serotonin receptors with the potential to treat depression and neurological conditions without hallucinogenic effects.

🌱 Triple Hair Group Signs Licensing Agreement for Brazil with Aché Strategic expansion into Brazil's $6B hair care market with exclusive rights granted to Aché.

📈 Quantum BioPharma Announces Private Placement $600M private placement to fund innovative treatments for neurodegenerative disorders through Lucid Psycheceuticals Inc.

🧫 Kane Biotech Converts Insider Loan and Reports AGM Results Governance updates and financial restructuring to support ongoing work in wound care and biofilm disruption.

💡 Follow the BioTech Weekly newsletter for more updates on biotech breakthroughs, regulatory milestones, and investment trends in life sciences.

#Biotech #Pharma #LifeSciences #ClinicalTrials #DrugDevelopment #HealthcareInnovation #SMA #CancerResearch #MentalHealth

Disclaimer: This podcast includes content generated with the help of large language models (LLM). Although care has been taken to ensure accuracy, LLMs can sometimes produce incorrect or misleading information. Listeners are advised to independently verify any details, provide feedback, and reach out.

🚨 BioTech Breakthroughs You Can't Miss – This Week in 7:30min Minutes 🎧

This week’s roundup features 14 key articles across 5 major categories (Strategic & Leadership Updates, Financing & Transactions, Clinical & Regulatory Developments, Policy & Market Shifts, Industry Vision & Commentary). From FDA policy moves and major layoffs to new funding rounds and pediatric trials, this summary highlights the momentum and challenges shaping biotech today.

🔬 Whether you're an investor, scientist, or biotech enthusiast, this episode is your shortcut to staying informed.

#biotech #pharmaceuticals #healthcareinnovation #podcast #drugdevelopment #clinicaltrials #biotechnews #lifesciences #investors #healthtech

Sources

🔍 Strategic Moves & Leadership Updates

• 👉 BMS banks on Wall Street vet for long-term strategy guidance— Chutes & Ladders
• 👉 FDA's CBER head dons extra hats with new CMO, CSO titles
• 👉 Isomorphic Labs taps CMO, plants roots in Boston

💰 Financing & Transactions

• 👉 PharmAla Files Preliminary Base Shelf Prospectus
• 👉 Aptose and Hanmi Enter New Loan Agreement to Advance Development of Tuspetinib
• 👉 PSYENCE GROUP INC. Announces Offering of up to C$600,000

🧪 Clinical & Regulatory News

• 👉 LabPMM® Receives New York State Approval for the NPM1 MRD Assay
• 👉 enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
• 👉 Biogen Initiates Phase 3 Pediatric Study of Omaveloxolone

⚖️ Policy & Market Shifts

• 👉 FDA blocks new clinical trials that ship cells from US to China
• 👉 Industry reacts as FDA reportedly puts cell and gene therapy chief on leave
• 👉 Prothena lays off 63% of employees after phase 3 trial fail
• 👉 Syncona shifts biotech investment strategy amid tough market

🌍 Long-Term Vision

• 👉 The World Can’t Wait: Biopharma’s “Gold